Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by greenupon Oct 07, 2019 11:32am
120 Views
Post# 30203678

RE:Q. Report scenario

RE:Q. Report scenarioNobody knows since nothing makes sense anymore, at one hand we have cron with 5m revenue and on the other hand aph. We will go up when big guys decide to flip the switch or aph decides to do something like announcing a jv.
treehugger2 wrote: I see some fellow-posters' projections for this quarter's earnings to have surpassed $150 millions; that's amazing and might very well prove to be accurate and realistic too. However, in a scenario (just scenario) where the number is say $130.000.000 exactly, what effect would this have on the share price? More importantly, how this impressive number would be perceived in a milieu where most of Aphria's cannabis counterparts lose money?
 
 
 



Bullboard Posts